Genetic Polymorphisms and Cisplatin- Related Nephrotoxicity
<p>Cis- diamminedichloroplatinum (cisplatin) is one of the most commonly used present day hemotherapeutic agents. It is used to treat a wide range of cancers including head and neck, lung, gastrointestinal tract, ovarian and genitourinary cancers. However, dose- limiting toxicity is often asso...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Libro |
| Publicado: |
Global Journal of Cancer Therapy - Peertechz Publications,
2015-01-07.
|
| Subjects: | |
| Acceso en liña: | Connect to this object online. |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|